the proximal blocker

A Carbonic Anhydrase Inhibitor that targets the proximal tubule. While a weak diuretic on its own, it is a powerful adjunct in refractory heart failure and metabolic alkalosis.

  • Mechanism: Inhibits Carbonic Anhydrase in the PCT. Blocks resorption of (Sodium Bicarbonate). Result: Alkaline diuresis, correction of metabolic alkalosis, chloride retention.
  • Dosing: HF (ADVOR protocol): 500 mg IV Daily. Glaucoma/IIH: 250–1000 mg PO in divided doses.
  • PK: Renally excreted.

indications

  • Acute Heart Failure: Adjunct to loops for improved decongestion (ADVOR Trial).
  • Metabolic Alkalosis: Especially “contraction alkalosis” from loops.
  • Glaucoma: Reduces aqueous humor production.
  • Altitude Sickness: Prophylaxis and treatment.

adverse effects

  • Metabolic Acidosis: Expected mechanism of action. Monitor bicarbonate.
  • Hypokalemia: Significant potassium wasting.
  • Paresthesias: Tingling in fingers/toes (common).
  • Kidney Stones: Calcium phosphate stones (alkaline urine).